87 episodes

The Oncology Brothers Podcast, led by Drs. Rahul and Rohit Gosain, is dedicated to bridging the gap between academic cancer centers and community oncology in the ever-evolving field of hematology & oncology. With a mission to disseminate crucial information to the medical community, this oncology podcast is not for medical advice but rather serves as a beacon for physicians, nurses, trainees, and advanced practice providers (APPs) involved in the care of cancer patients.

Drs. Rahul and Rohit Gosain, both esteemed oncologists, bring a wealth of experience and expertise from their general community practice to these discussions. Through short and engaging interviews with world-renowned researchers, clinicians, hematologists, and oncologists, they present practice-changing data in a concise, bite-sized format.

Get the latest FDA approvals news, oncology conference highlights, and treatment algorithms in 25 minutes or less. Conversations center around common cancers you see in your clinic like breast cancer, prostate cancer, kidney cancer, bladder cancer, lung cancer, and GI cancers. With new indications and approvals, we talk about how to incorporate this data in your day to day clinical practice.

Each episode includes visual presentations so you can follow along within the podcast players and on YouTube @oncbrothers. These visual tools and algorithms will provide an outline on what is covered in each episode. Immediately apply the latest insights and advancements in your daily practice, ensuring the delivery of optimal cancer care to patients within your local communities.

If you want to navigate the complexities of your hematology & oncology practice and stay current, the Oncology Brothers Podcast offers invaluable insights and practical takeaways to enhance your professional journey and improve patient outcomes. For more information, please visit: www.oncbrothers.com, and connect with us on Twitter/X/Instagram/TikTok: @oncbrothers, or email us at info@oncbrothers.com

Oncology Brothers: Practice-Changing Cancer Discussions Oncology Brothers

    • Health & Fitness
    • 4.8 • 28 Ratings

The Oncology Brothers Podcast, led by Drs. Rahul and Rohit Gosain, is dedicated to bridging the gap between academic cancer centers and community oncology in the ever-evolving field of hematology & oncology. With a mission to disseminate crucial information to the medical community, this oncology podcast is not for medical advice but rather serves as a beacon for physicians, nurses, trainees, and advanced practice providers (APPs) involved in the care of cancer patients.

Drs. Rahul and Rohit Gosain, both esteemed oncologists, bring a wealth of experience and expertise from their general community practice to these discussions. Through short and engaging interviews with world-renowned researchers, clinicians, hematologists, and oncologists, they present practice-changing data in a concise, bite-sized format.

Get the latest FDA approvals news, oncology conference highlights, and treatment algorithms in 25 minutes or less. Conversations center around common cancers you see in your clinic like breast cancer, prostate cancer, kidney cancer, bladder cancer, lung cancer, and GI cancers. With new indications and approvals, we talk about how to incorporate this data in your day to day clinical practice.

Each episode includes visual presentations so you can follow along within the podcast players and on YouTube @oncbrothers. These visual tools and algorithms will provide an outline on what is covered in each episode. Immediately apply the latest insights and advancements in your daily practice, ensuring the delivery of optimal cancer care to patients within your local communities.

If you want to navigate the complexities of your hematology & oncology practice and stay current, the Oncology Brothers Podcast offers invaluable insights and practical takeaways to enhance your professional journey and improve patient outcomes. For more information, please visit: www.oncbrothers.com, and connect with us on Twitter/X/Instagram/TikTok: @oncbrothers, or email us at info@oncbrothers.com

    • video
    How to Treat Metastatic Non-Small Cell Lung Cancer w/o Targeted Mut in Front-line - Dr. Preeshagul

    How to Treat Metastatic Non-Small Cell Lung Cancer w/o Targeted Mut in Front-line - Dr. Preeshagul

    Welcome back to the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain are joined by Dr. Isabel Preeshagul from Memorial Sloan Kettering Cancer Center to discuss metastatic non-small cell lung cancer treatment without actionable mutations in first-line settings.
    They dive into the importance of comprehensive testing, strategies for using immunotherapy and chemotherapy combinations, and emerging second-line treatment options. Dr. Preeshagul shares insights on targeting KRAS G12C, HER2 mutation with TDXD, and the potential combination of ramucirumab with pembrolizumab.
    Tune in for a detailed discussion on the latest advancements in non-small cell lung cancer treatment. Don't miss out on valuable insights from this informative episode of the Oncology Brothers podcast!

    • 25 min
    • video
    How to Treat Non-Small Cell Lung Cancer with Actionable Mutations with Dr. Balazs Halmos

    How to Treat Non-Small Cell Lung Cancer with Actionable Mutations with Dr. Balazs Halmos

    Welcome to the Oncology Brothers Podcast! Join Drs. Rahul & Rohit Gosain in this episode as they welcome Dr. Balazs Halmos, a thoracic medical oncologist from Montefiore-Einstein Comprehensive Cancer Center, to discuss the current landscape of metastatic non-small cell lung cancer with actionable mutations in first-line settings.
    In this informative episode, they cover a wide range of topics including the importance of NGS testing, treatment options for various actionable mutations such as EGFR, ALK, ROS1, RET rearrangements, and more. Dr. Halmos provides valuable insights into decision-making processes, sequencing treatments, and managing toxicities associated with targeted therapies.
    Don't miss out on this insightful discussion that sheds light on the rapidly evolving space of precision medicine in lung cancer treatment. Stay informed and learn how identifying and targeting specific mutations can optimize treatment outcomes and improve patient quality of life.Tune in to the Oncology Brothers Podcast for expert insights and discussions on the latest developments in oncology.
    Subscribe now to stay updated on their informative episodes!

    • 26 min
    • video
    How to Treat Small Cell Lung Cancer using Treatment Algorithm with Dr. Eric Singhi

    How to Treat Small Cell Lung Cancer using Treatment Algorithm with Dr. Eric Singhi

    Join the Oncology Brothers, Rahul and Rohit Gosain, in this insightful podcast episode as they dive into the world of small cell lung cancer with special guest Dr. Eric Singhi, a thoracic medical oncologist from MD Anderson Cancer Center.
    Key Points:•⁠  ⁠The Adriatic study's impact on improving survival with Durvalumab in limited-stage disease.•⁠  ⁠Treatment options for extensive-stage disease, including second-line therapies like Lurbinectedin and the recent approval of Tarlatamab.•⁠  ⁠The significance of individualized treatment decisions and ongoing research in small cell lung cancer management.
    In this episode, Dr. Singhi discusses the management of limited-stage small cell lung cancer, the impact of the recent Adriatic study on treatment approaches, and the use of immunotherapy in both limited and extensive-stage disease. The conversation also delves into the role of PCI, the use of Trilaciclib in extensive stage, and the recent FDA approval of Tarlatamab for small cell lung cancer.
    Discover the latest advancements and treatment options for small cell lung cancer, including insights on second-line treatments, consolidation radiation, and the management of patients with driver mutations. Dr. Singhi also highlights the importance of patient advocacy groups like the Small Cell Smashers in providing support for individuals with small cell lung cancer.
    Tune in to this episode for a comprehensive overview of the current treatment landscape for small cell lung cancer and gain valuable insights from Dr. Singhi's expertise in the field. Don't miss out on this informative discussion on the Oncology Brothers podcast!

    • 20 min
    • video
    GI Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Mark Lewis

    GI Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Mark Lewis

    Join Drs. Rohit Gosain and Rahul Gosain as they dive into the practice-changing updates from ASCO 2024 conference. In this episode, they are joined by Dr. Mark Lewis to cover key studies in GI malignancies from the conference.
    In this episode, they discuss:•⁠  ⁠The ESOPEC study comparing concurrent chemoradiation versus periop FLOT regimen for upper GI adenocarcinoma.•⁠  ⁠The ARMANI trial on switch maintenance with ramucirumab plus paclitaxel.•⁠  ⁠The TRANSMET trial exploring chemotherapy followed by liver transplantation for metastatic liver-confined colorectal cancer.•⁠  ⁠The COLLISION trial comparing surgery versus ablation for small size colorectal liver metastatic disease.•⁠  ⁠The COMMIT study looking at the use of atezolizumab with chemotherapy in first-line treatment for MSI high metastatic colorectal cancer.These studies highlight the importance of biomarker testing and a multidisciplinary approach in the treatment of cancer.
    Tune in to gain valuable insights from ASCO 2024 and stay informed about the latest advancements in oncology. Don't forget to check out their lung, GU, and breast cancer highlights from the conference as well.Stay connected with the Oncology Brothers for more updates and discussions on the latest in the world of oncology. Thank you for tuning in!

    • 27 min
    • video
    GU Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Toni Choueiri

    GU Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Toni Choueiri

    Welcome to another insightful episode of the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain are joined by Dr. Toni Choueiri, a GU Medical Oncologist from Dana-Farber Cancer Institute, to discuss key abstracts from ASCO 2024.
    They delve into topics such as the impact of the EV302 study on metastatic bladder cancer, the potential role of ctDNA as a biomarker in bladder cancer, real-world data on metastatic RCC, and the PSMA-4 study in prostate cancer. The discussion covers patient-reported outcomes, treatment strategies, and the evolving landscape of oncology care.
    Tune in to gain valuable insights into the latest advancements in oncology and how they are shaping the standard of care for patients. Don't miss out on this engaging conversation with experts in the field. Subscribe to the Oncology Brothers podcast for more updates from the world of oncology.
    Website: http://www.oncbrothers.com/
    Twitter: https://twitter.com/oncbrothers
    Contact us at info@oncbrothers.com

    • 21 min
    • video
    Breast Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Erika Hamilton

    Breast Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Erika Hamilton

    Join the Oncology Brothers podcast as they dive into the highlights from ASCO 2024 with special guest Dr. Erika Hamilton, a breast medical oncologist from the Sarah Cannon Research Institute. In this episode, they discuss key abstracts in the world of breast cancer, including updates on RxPonder, PostMonarch, INAVO120, DESTINY-Breast06, and the Emerald Trial. Dr. Hamilton provides valuable insights on biomarker testing, CDK4/6 inhibitors, and groundbreaking advancements in HER2-targeted therapies. Discover how these studies are shaping treatment strategies for hormone receptor positive, HER2-low, and HER2-positive breast cancer patients. Don't miss out on this informative discussion packed with practical insights for community oncologists. Stay tuned for more ASCO 2024 highlights from the Oncology Brothers podcast.
    Website: http://www.oncbrothers.com/
    Twitter: https://twitter.com/oncbrothers
    Contact us at info@oncbrothers.com

    • 22 min

Customer Reviews

4.8 out of 5
28 Ratings

28 Ratings

aby7623 ,

My go to stay in touch with rapidly evolving field

Amazing resource! Can’t emphasize enough how resourceful your podcast has been. Wonderful resource for staying uptodate with latest and greatest!
Love the discussions with the experts which are succinct and yet so informative!

bbbatfsi ,

Most useful podcast in oncology.

Oncology brothers are doing phenomenal job in keeping community oncologist updated, the algorithms are very helpful, succinct and updated. It’s the best podcast out there for your time, I do not miss any of their podcast.

Mudpiles ,

Stay up to date in oncology

THANK YOU! I can’t stress how important your podcast has been for me to stay up to date in this ever changing field. Your podcast has helped me stay on top of all major updates - which has been translating in helping my patients. You two brothers have been doing an amazing job!

Top Podcasts In Health & Fitness

The School of Greatness
Lewis Howes
Huberman Lab
Scicomm Media
On Purpose with Jay Shetty
iHeartPodcasts
ZOE Science & Nutrition
ZOE
Passion Struck with John R. Miles
John R. Miles
Ten Percent Happier with Dan Harris
Ten Percent Happier

You Might Also Like

Two Onc Docs
Sam and Karine
Oncology Today with Dr Neil Love
Research To Practice
Research To Practice | Oncology Videos
Dr Neil Love
ASCO Guidelines
American Society of Clinical Oncology (ASCO)
ASCO Daily News
American Society of Clinical Oncology (ASCO)
Blood Cancer Talks
Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff